- Home
- TNFA vs ATNF Comparison
TNFA vs ATNF Comparison
Compare TNFA & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNFA
- ATNF
- Stock Information
- Founded
- TNFA 2014
- ATNF 2016
- Country
- TNFA United States
- ATNF United States
- Employees
- TNFA N/A
- ATNF 4
- Industry
- TNFA
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- TNFA
- ATNF Health Care
- Exchange
- TNFA NYSE
- ATNF Nasdaq
- Market Cap
- TNFA 3.7M
- ATNF 2.6M
- IPO Year
- TNFA N/A
- ATNF N/A
- Fundamental
- Price
- TNFA $1.20
- ATNF $2.50
- Analyst Decision
- TNFA
- ATNF
- Analyst Count
- TNFA 0
- ATNF 0
- Target Price
- TNFA N/A
- ATNF N/A
- AVG Volume (30 Days)
- TNFA 27.7K
- ATNF 738.2K
- Earning Date
- TNFA 11-29-2024
- ATNF 11-26-2024
- Dividend Yield
- TNFA N/A
- ATNF N/A
- EPS Growth
- TNFA N/A
- ATNF N/A
- EPS
- TNFA N/A
- ATNF N/A
- Revenue
- TNFA N/A
- ATNF N/A
- Revenue This Year
- TNFA N/A
- ATNF N/A
- Revenue Next Year
- TNFA N/A
- ATNF $54.15
- P/E Ratio
- TNFA N/A
- ATNF N/A
- Revenue Growth
- TNFA N/A
- ATNF N/A
- 52 Week Low
- TNFA $1.15
- ATNF $1.16
- 52 Week High
- TNFA $10.68
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- TNFA 36.11
- ATNF 42.14
- Support Level
- TNFA $1.26
- ATNF $2.82
- Resistance Level
- TNFA $1.44
- ATNF $3.60
- Average True Range (ATR)
- TNFA 0.13
- ATNF 0.42
- MACD
- TNFA -0.02
- ATNF -0.20
- Stochastic Oscillator
- TNFA 7.69
- ATNF 4.39
About TNFA TNF PHARMACEUTICALS INC EFFEC
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.